'''Ciclesonide''' is a [[glucocorticoid]] used to treat [[asthma]] and [[allergic rhinitis]]. It is marketed under the brand names '''Alvesco''' for asthma and '''Omnaris''', '''Omniair''', and '''Zetonna''' for hay fever in the US and Canada. Phase 3 trials for the hay fever indication outside of the US are ongoing.<ref>{{cite web |url=http://www.nycomed.com/Nycomed.MCms/Templates/Nycomed/Products/Products.aspx?NRMODE=Published&NRNODEGUID=%7b95B0E8B9-D1B3-4D3D-8B77-26AE2795B0F9%7d&NRORIGINALURL=%2fen%2fMenu%2fProducts%2fProduct%2boverview&NRCACHEHINT=Guest |year=2009 |work=Products |title=OMNARIS/OMNAIR |publisher=Nycomed International Management GmbH |accessdate=2009-07-30 |deadurl=yes |archiveurl=https://web.archive.org/web/20090202014705/http://nycomed.com/Nycomed.MCms/Templates/Nycomed/Products/Products.aspx?NRMODE=Published&NRNODEGUID=%7B95B0E8B9-D1B3-4D3D-8B77-26AE2795B0F9%7D&NRORIGINALURL=%2Fen%2FMenu%2FProducts%2FProduct+overview&NRCACHEHINT=Guest |archivedate=February 2, 2009 |df= }}</ref> The drug was approved for adults and children 12 and over by the US [[Food and Drug Administration]] in October 2006.<ref>{{cite web|url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108773.htm|title=FDA NEWS RELEASE. FDA Approves New Treatment for Allergies.|date=2006-10-23|publisher=[[Food and Drug Administration (United States)|Food and Drug Administration]]|accessdate=2009-07-30}}</ref> Side effects of the medication include headache, nosebleeds, and inflammation of the nose and throat linings.<ref name=mutch2007>{{cite journal |last1=Mutch |first1=Elaine |last2=Nave |first2=Ruediger |last3=McCracken |first3=Nigel |last4=Zech |first4=Karl |last5=Williams |first5=Faith M. |year=2007 |title=The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue |journal=Biochemical Pharmacology |volume=73 |issue=10 |pages=1657â€“64 |pmid=17331475 |doi=10.1016/j.bcp.2007.01.031}}</ref>
